Aspira Women’s Health amends 8-K to disclose former CEO Buhle separation agreement, USD 200,000 severance
Aspira Women's Health Inc. AWHL | 0.00 |
- Aspira Women’s Health filed an amended 8-K to update disclosures on former CEO Michael Buhle’s separation terms.
- Separation agreement signed June 27, executed June 28; expected to become effective around July 6 following a seven-day revocation period.
- Cash severance set at USD 200,000, paid in installments; USD 4,615.38 slated for the July 15 payroll run.
- Company to cover six months of COBRA health and dental premiums, subject to earlier cutoff if comparable coverage is obtained elsewhere.
- Vesting acceleration planned for options on 64,583 shares at USD 0.07; other unvested awards forfeited, with post-exercise sale restrictions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000050), on July 07, 2026, and is solely responsible for the information contained therein.
